K961010

Substantially Equivalent

ACCUSIGN DOA 3,ACCUSIGN DOA, ACCUSIGN BAR/BZO/MTD, BIOSIGN DOA 3, BIOSIGN BAR/BZO/MTD

Applicant: Princeton BioMeditech Corp.
Product code: DIS
Advisory panel: Clinical Toxicology
Date received: 1996-03-13
Decision date: 1996-06-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Monmouth Junction, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.